Claire Kizlik‐Masson

Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin‐induced thrombocytopenia antibodies

Caroline Vayne, Eve‐Anne Guéry, Claire Kizlik‐Masson et al. · British Journal of Haematology · 2017 · 62 citations · Full text

Medicine, Hematology, Immunology +12

Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia

Claire Kizlik‐Masson, Quentin Deveuve, Yuhang Zhou et al. · Blood · 2019 · 41 citations · Full text

Medicine, Immunology, Molecular Biology +16

5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin‐induced thrombocytopenia antibodies

Claire Kizlik‐Masson, Caroline Vayne, Steven E. McKenzie et al. · Journal of Thrombosis and Haemostasis · 2017 · 33 citations · Full text

Medicine, Hematology, Immunology +12

Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France

Camille Martin, Claire Kizlik‐Masson, André Pèlegrin et al. · mAbs · 2017 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmaceutics +16

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation

Camille Martin, Guillaume Brachet, Cyril Colas et al. · Pharmaceuticals · 2019 · 15 citations · Full text

Pharmacy, Biochemistry, Biotechnology +17